Literature DB >> 6982847

An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

P K Lala, I F McKenzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6982847      PMCID： PMC1555568     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  44 in total

1.  Ly phenotype of T cells cytotoxic for syngeneic mouse mammary tumors: evidence for T cell interactions.

Authors:  O Stutman; F W Shen; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.

Authors:  R C Burton; N L Warner
Journal:  J Natl Cancer Inst       Date:  1977-03       Impact factor: 13.506

3.  Thy and Ly markers on lymphocytes initiating tumor rejection.

Authors:  M Nelson; D S Nelson; I F McKenzie; R V Blanden
Journal:  Cell Immunol       Date:  1981-05-01       Impact factor: 4.868

4.  Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood.

Authors:  S Garnis; P K Lala
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

5.  Distribution of Lyt phenotypes in thymocyte subpopulations as measured by flow microfluorometry: selective enrichment of Lyt 1+23- thymocytes.

Authors:  I Betel; B J Mathieson; S O Sharrow; R Asofsky
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

6.  T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients.

Authors:  P A Kaszubowski; G Husby; K S Tung; R C Williams
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

7.  Quantitation of lymphocytes and T-cell subsets in patients with disseminated cancer.

Authors:  M A Cobleigh; D P Braun; J E Harris
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

8.  Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1.

Authors:  P M Hogarth; T A Potter; F N Cornell; R McLachlan; I F McKenzie
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

9.  T cell subset interactions in the regulation of syngeneic tumor immunity.

Authors:  L L Perry; M I Greene
Journal:  Fed Proc       Date:  1981-01

10.  Ly phenotype of cytotoxic T cells for syngeneic tumor.

Authors:  H Shiku; T Takahashi; M A Bean; L J Old; H F Oettgen
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307
View more
  4 in total

1.  Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.

Authors:  N K Khoo; F P Chan; M N Saarloos; P K Lala
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

2.  Tumor infiltrating lymphocytes of spontaneous versus transplanted mouse mammary tumors.

Authors:  W Z Wei; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers.

Authors:  M B Mokyr; E Barker
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2.

Authors:  R S Parhar; P K Lala
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.